Benjamin Hickey insider trades
Open-market stock purchases and sales by Benjamin Hickey, President, RayzeBio Org. at Bristol Myers Squibb Co, from SEC Form 4 filings since Oct 1, 2018.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Mar 10, 2026 | BMY Bristol Myers Squibb Co | Bought (not open market) | — |
| Mar 10, 2026 | BMY Bristol Myers Squibb Co | Bought (not open market) | — |
| Feb 27, 2026 | BMY Bristol Myers Squibb Co | Sold (not open market) | $104K |
| Feb 27, 2026 | BMY Bristol Myers Squibb Co | Bought (not open market) | — |
| Feb 1, 2026 | BMY Bristol Myers Squibb Co | Sold (not open market) | $210K |
| Feb 1, 2026 | BMY Bristol Myers Squibb Co | Bought (not open market) | — |
| Dec 5, 2025 | MURA Mural Oncology plc | Sold (not open market) | $28.3K |
| Dec 5, 2025 | MURA Mural Oncology plc | Sold (not open market) | $54.2K |
| Dec 5, 2025 | MURA Mural Oncology plc | Sold (not open market) | $22.1K |